A comprehensive 15-year analysis of Taiwan’s cancer registry data reveals a transformative shift in lung cancer diagnosis patterns, with particularly striking results among never-smoking women. The study, published in The Lancet Regional Health – Western Pacific, documents a 68% increase in early-stage adenocarcinoma diagnoses between 2011 and 2019, coinciding with expanded access to self-initiated low-dose computed tomography screening through private healthcare providers.
While early detection rates surged, late-stage diagnoses remained relatively stable, and notably, overall lung cancer mortality declined by 15% during this period. This pattern suggests genuine clinical benefits beyond mere increased detection. Dr. Ming-Chia Lee and colleagues at National Taiwan University analyzed over 200,000 lung cancer cases, offering valuable insights into how opportunistic, patient-driven screening models can complement formal public health initiatives. The findings highlight opportunities for healthcare systems worldwide seeking to improve early detection outcomes.
Read the full article on GMJ Newsroom.
Was this article helpful?
